Clinical Trial

Oral Health, Saliva Viscosity and Composition in Oculo-Pharyngeal Muscular Dystrophy (OPMD)

Recruiting
View on ClinicalTrials.gov →
Summary
The goal of this observational study is to explore whether oral health and saliva viscosity and composition in Oculopharyngeal Muscular Dystrophy (OPMD) is different from control subjects. The main questions it aims to answer are: Do swallowing disturbances in OPMD adversely affect oral health? Is saliva thickness (viscosity) is increased in OPMD? Does saliva in OPMD contains biochemical markers of the disease?
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-08-05; most recent amendment 2026-01-25.
Trial Details
NCT Number NCT07118280
Lead Sponsor Sheba Medical Center
Conditions Oculopharyngeal Muscular Dystrophy
Enrollment 100 participants
Start Date 2023-03-01
Primary Completion 2027-03 (estimated)
Study Completion 2027-03 (estimated)
Updated on ClinicalTrials.gov 2026-01-27